BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £196.29m
- £244.13m
- BDT44.39bn
- 93
- 96
- 78
- 100
REG - Beximco Pharmaceut - Holdings in Company
AnnouncementREG - Beximco Pharmaceut - Half Year Results 2022-23
AnnouncementREG - Beximco Pharmaceut - Payment of Cash Dividend
AnnouncementREG - Beximco Pharmaceut - Annual General Meeting Statement
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - AGM Notification
AnnouncementREG - Beximco Pharmaceut - Financial Results for the First Quarter
AnnouncementREG - Beximco Pharmaceut - Results for the 12-month period ended 30 June 2022
AnnouncementREG - Beximco Pharmaceut - Notification of Preliminary Results and AGM
AnnouncementREG - Beximco Pharmaceut - Q3 Financial Results
AnnouncementREG - Beximco Pharmaceut - Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC
AnnouncementREG - Beximco Pharmaceut - MPP sub-license for Pfizer’s COVID-19 treatment
AnnouncementREG - Beximco Pharmaceut - Half Year Results 2021-22
AnnouncementREG - Beximco Pharmaceut - Payment of Cash Dividend
AnnouncementREG - Beximco Pharmaceut - License to produce molnupiravir for COVID-19
AnnouncementREG - Beximco Pharmaceut - World's first generic version of Pfizer’s Paxlovid
AnnouncementREG - Beximco Pharmaceut - Annual General Meeting Statement
AnnouncementREG - Beximco Pharmaceut - Delivery of COVID-19 vaccine doses
Announcement